Discovery and Optimization of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Pharmacophore- and Docking-Based Virtual Screening
- 30 September 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 58 (20) , 8166-8181
Abstract
Histone methyltransferases are involved in various biological functions, and these methylation regulating enzymes’ abnormal expression or activity has been noted in several human cancers. Within this context, SET domain-containing (lysine methyltransferase) 7 (SET7, also called KMT7, SETD7, SET9) is of increasing significance due to its diverse roles in biological functions and diseases, such as diabetes, cancers, alopecia areata, atherosclerotic vascular disease, HIV, and HCV. In this study, DC-S100, which was discovered by pharmacophore- and docking-based virtual screening, was identified as the hit compound of SET7 inhibitor. Structure–activity relationship (SAR) analysis was performed on analogs of DC-S100 and according to the putative binding mode of DC-S100, structure modifications were made to improve its activity. Of note, compounds DC-S238 and DC-S239, with IC50 values of 4.88 and 4.59 μM, respectively, displayed selectivity for DNMT1, DOT1L, EZH2, NSD1, SETD8, and G9a. Taken together, DC-S238 and DC-S239 can serve as leads for further investigation as SET7 inhibitors and the chemical toolkits for functional biology studies of SET7.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2012AA01A305, 2012AA020302, 2014ZX09507002, 2015CB910304)
- National Natural Science Foundation of China (21210003, 21472208, 81230076, 8143000629, 91229204)
This publication has 103 references indexed in Scilit:
- Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual ScreeningJournal of Medicinal Chemistry, 2013
- The Histone Methyltransferase SUV39H1 Suppresses Embryonal Rhabdomyosarcoma Formation in ZebrafishPLOS ONE, 2013
- The Methyltransferase Set7/9 (Setd7) Is Dispensable for the p53-Mediated DNA Damage Response In VivoMolecular Cell, 2011
- Novel 3,5-Bis(bromohydroxybenzylidene)piperidin-4-ones as Coactivator-Associated Arginine Methyltransferase 1 Inhibitors: Enzyme Selectivity and Cellular ActivityJournal of Medicinal Chemistry, 2011
- Interplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma proteinThe EMBO Journal, 2010
- Identification of Non-Peptide Malignant Brain Tumor (MBT) Repeat Antagonists by Virtual Screening of Commercially Available CompoundsJournal of Medicinal Chemistry, 2010
- The Cellular Lysine Methyltransferase Set7/9-KMT7 Binds HIV-1 TAR RNA, Monomethylates the Viral Transactivator Tat, and Enhances HIV TranscriptionCell Host & Microbe, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Negative regulation of NF‐κB action by Set9‐mediated lysine methylation of the RelA subunitThe EMBO Journal, 2009
- Regulation of Estrogen Receptor α by the SET7 Lysine MethyltransferaseMolecular Cell, 2008